Stockholm, Sweden—A joint session of the European Hematology Association (EHA) and the American Society of Hematology (ASH) was held during the 18th Annual Congress of EHA on June 15, 2013. Ulrich Jäger, MD, President of EHA and Medical University of Vienna, Austria, and Janis L. Abkowitz, MD, President of ASH and University of Washington, Seattle, moderated a well-attended plenary session titled, “Challenges Associated with Delivering Cancer Care in Times of Economic Crisis.”
Many presentations at the 18th Congress of the European Hematology Association (EHA) addressed the topic of multiple myeloma (MM). The following description is a brief summary of key data related to this tumor type.
Ixazomib (MLN9708) plus Lenalidomide and Dexamethasone in Older Patients with Newly Diagnosed MM
Results 1 - 2 of 2